Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:LCI

Lannett (LCI) Stock Price, News & Analysis

Lannett logo

About Lannett Stock (NYSE:LCI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.65
$2.51
52-Week Range
N/A
Volume
280,600 shs
Average Volume
92,067 shs
Market Capitalization
$7.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

LCI Stock News Headlines

Lucky Core Industries Ltd.
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself. Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit. Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too.
LANNETT SHARES UPDATE
Why Lannett (LCI) Stock Is Down Today
See More Headlines

LCI Stock Analysis - Frequently Asked Questions

Lannett Company, Inc. (NYSE:LCI) announced its earnings results on Wednesday, November, 3rd. The company reported ($1.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.00) by $0.08. The firm earned $101.53 million during the quarter, compared to analyst estimates of $98.62 million.

Shares of Lannett reverse split on the morning of Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lannett investors own include Bristol-Myers Squibb (BMY), Akorn (AKRX), Micron Technology (MU), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), AT&T (T) and Bank of America (BAC).

Company Calendar

Last Earnings
11/03/2021
Today
2/22/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
CUSIP
51601210
Employees
810
Year Founded
N/A

Profitability

Net Income
$-231,620,000.00
Pretax Margin
-62.67%

Debt

Sales & Book Value

Annual Sales
$340.58 million
Book Value
($23.34) per share

Miscellaneous

Free Float
9,354,000
Market Cap
$7.38 million
Optionable
Optionable
Beta
0.95

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NYSE:LCI) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners